Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans

Am J Manag Care. 2024;30(3):107-108. https://doi.org/10.37765/ajmc.2024.89510 _____ Takeaway Points * The out-of-pocket costs of some noninsulin diabetes medications are higher than the out-of-pocket costs of insulin. * Policy makers and employers designing health benefit plans should consider the t...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of managed care 2024-03, Vol.30 (3), p.107-108
Main Authors: Quach, Jennie, Midlam, Cody, Sell, Chantell, Levin-Scherz, Jeff
Format: Article
Language:English
Subjects:
Costs
Diabetes
Drugs
Employers
Health insurance
Insulin
Pharmacists
Public health
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Am J Manag Care. 2024;30(3):107-108. https://doi.org/10.37765/ajmc.2024.89510 _____ Takeaway Points * The out-of-pocket costs of some noninsulin diabetes medications are higher than the out-of-pocket costs of insulin. * Policy makers and employers designing health benefit plans should consider the total burden of out-of-pocket drug costs. _____ Public policy attention has focused on the out-of-pocket cost of insulin,1 but little information is available on out-of-pocket costs of other diabetes drugs. Author Disclosures: Drs Midlam, Sell, and Levin-Scherz are employees of WTW and Ms Quach is a former employee of WTW, a consulting firm that works with pharmacy benefit managers to procure medications for employer-sponsored health plans. Authorship Information: Concept and design (JQ, CM, CS, JL-S); acquisition of data (JQ); analysis and interpretation of data (JQ, CM, CS, JL-S); drafting of the manuscript (JQ, CM, CS, JL-S); critical revision of the manuscript for important intellectual content (JQ, CM, CS, JL-S); and statistical analysis (JQ).
ISSN:1088-0224
1936-2692
1936-2692
DOI:10.37765/ajmc.2024.89510